抑制6-pyruvoyl-tetrahydropterin合成酶可以促进多发性硬化症的复髓化
Hui Xiao1,2, Ying Long1,3, Yong-Shun Guo4
1Institute of Neuroscience, CAS Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, 200031, China.
BMC medicine
|November 6, 2025
概括
6-pyruvoyl-tetrahydropterin合成酶 (PTS) 抑制了多发性硬化症 (MS) 中的寡头细胞前体细胞 (OPC) 增殖. 在OPC中抑制PTS促进了回髓化,可能是MS患者的治疗策略.
科学领域:
- 神经免疫学 神经免疫学
- 细胞生物学 细胞生物学
- 脱线性疾病 脱线性疾病
背景情况:
- 多发性硬化症 (MS) 涉及中枢神经系统脱髓化,神经炎症和神经元损失.
- 目前的多发性硬化疗法可以控制疾病活动,但神经保护仍然是一个挑战.
- 氧基基细胞前体细胞 (OPC) 功能障碍阻碍了MS中的复髓化.
研究的目的:
- 研究6-pyruvoyl-tetrahydropterin合成酶 (PTS) 在多发性硬化症期间对寡细胞命运的作用.
- 阐明MS中OPC功能障碍的分子机制.
主要方法:
- 重新分析了来自人类和小鼠寡细胞系细胞 (OLC) 的单细胞测序数据.
- 在MS模型中利用针对OLC的条件淘汰赛小鼠来评估PTS功能.
- 进行了转录基因分析,以了解PTS对疾病过程的影响.
主要成果:
- 在MS患者中观察到OPC中的PTS表达升高.
- 在OPC中特别淘汰PTS的小鼠显示,实验性自身免疫脑炎 (EAE) 严重程度和脱髓化减少.
- 在OPC中抑制PTS增强了EAE期间的增殖和复髓化.
- PTS倒置激活了胆固醇生物合成,促进了OPC的扩散.
结论:
- PTS作为欧盟成员国OPC扩散的负调节者.
- 消毒PTS是一种潜在的治疗点,可以促进MS的复髓化.
相关概念视频
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Biosynthesis of Nucleic Acids
Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...


